Myeloproliferative neoplasms: open trials in Argentina

3 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
CABA · Capital Federal
Registry updated 2026-11-09
NCT07357727
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Hospital de Clinicas Jose de San Martin, Buenos Aires · Hospital Italiano de Buenos Aires, CABA · CABA · FUNDALEU, Capital Federal · Hospital Privado de Cordoba, Córdoba
Registry updated 2026-11-06
NCT07623161
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Trial Treatment · Phase 3 · Takeda
Swiss Medical Center - Barrio Parque, Buenos Aires · Hospital Aleman (HA) Deutsches Hospital, Buenos Aires · BRCR Global, Córdoba · Hospital Universitario Austral, Pilar · Instituto Médico de la Fundación Estudios Clínicos, Rosario · Hospital Privado de Rosario, Rosario
Registry updated 2026-11-06

This page is not medical advice. Talk to your doctor before contacting a trial.

Asciminib Roll-over Study